我们的网站为什么显示成这样？

可能因为您的浏览器不支持样式，您可以更新您的浏览器到最新版本，以获取对此功能的支持，访问下面的网站，获取关于浏览器的信息：

|本期目录/Table of Contents|

氟伐他汀对动脉粥样硬化大鼠胸主动脉肾上腺髓质素受体表达的影响(PDF)

《心脏杂志》[ISSN:1009-7236/CN:61-1268/R]

期数:
2008年第3期
页码:
291-294，300
栏目:
基础研究
出版日期:
2008-05-20

文章信息/Info

Title:
Effects of fluvastatin on adrenomedullin receptor expression in atherosclerosis rats
作者:
张敬1; 舒青2; 郑强荪1; 王菲1; 赵子文1; 张志钢1; 王彬1
第四军医大学: 1.唐都医院心内科, 陕西 西安 710038,2.基础部遗传学与发育生物学教研室, 陕西 西安 710033
Author(s):
ZHANG Jing1;  SHU Qing2;  ZHENG Qiangsun1;  WANG Fei1;  ZHAO Ziwen1;  ZHANG Zhigang1;  WANG Bin1
1.Department of Cardiology, Tangdu Hospital, Fourth Military Medical University, Xi’an 710038, Shaanxi, China; 2.Department of Medical Genetics and Development Biology; School of Basic Medicine, Fourth Military Medical University, Xi’an 710033, Shaanxi, China
关键词:
动脉粥样硬化; 肾上腺髓质素受体; 氟伐他汀
Keywords:
atherosclerosis; adrenomedullin receptor;  Fluvastatin
分类号:
R541.4
DOI:
-
文献标识码:
A
摘要:
目的 探讨肾上腺髓质素受体（ADMR）在动脉粥样硬化(AS)大鼠胸主动脉病变时的变化及氟伐他汀对ADMR表达的影响。方法 将SD大鼠随机分为 3 组：正常对照组、AS模型组和氟伐他汀干预组。采用喂养高脂饲料 (正常饲料基础上加入 30 g/kg胆固醇、5 g/kg胆酸钠、2 g/kg丙基硫氧嘧啶、50 g/kg精制糖、100 g/kg猪油)加维生素D3制备AS动物模型，氟伐他汀 20 mg/(kg·d)灌胃 12 周。用RTPCR和Western印记法分别检测各组胸主动脉中ADMR mRNA和蛋白的表达情况。结果 氟伐他汀干预组大鼠与AS组比较，体质量差异无统计学意义；与AS组相比，干预组三酰甘油（TG）、总胆固醇（CHOL）显著下降（P<001）；与正常对照组相比，模型组TG、CHOL明显升高（P<0.05）；与正常对照组相比，模型组、干预组血钙均明显升高（P<0.05）。氟伐他汀干预组大鼠胸主动脉中ADMR mRNA及蛋白的表达均显著高于AS组（P<0.05)。结论 氟伐他汀可上调AS大鼠胸主动脉ADMR基因和蛋白的表达，ADMR可能参与了氟伐他汀抗动脉粥样硬化的作用。
Abstract:
AIM To investigate the changes of ADMR (adrenomedullin receptor) in ascending aorta of AS rats and the effects of fluvastatin on the expression of ADMR mRNA and protein. METHODS Fortyfive male SD rats were randomly divided into 3 groups: normal control group (N), atherosclerosis group (AS) and atherosclerosis rats treated with fluvastatin (F). Group AS were fed with high lipid feedstuff (including 30 g/L cholesterol, 5 g/kg cholic acid natrium, 2 g/kg propyl thiouracil, 50 g/kg refined sugar, 100 g/kg lard oil) plus vitamin D3, and group F were fed as group AS, followed with fluvastatin (20 mg/kg/d, intragastric administration). The mRNA and protein expressions of ADMR in ascending aorta of rats were assessed by reverse transcription PCR and Western blot respectively. RESULTS ①The values of body weight showed no significant difference between group F and group AS. The triglyceride and cholesterol levels in group F were reduced significantly compared with those in group AS (P<001) and the levels in group AS were increased significantly compared with those in group N (P<005). The blood serum calculus levels in group AS and group F increased significantly compared with those in group N (P<005). ②The ADMR mRNA level and the expressions of ADMR protein in the ascending aorta in group F increased compared with those in group AS (both P<005). CONCLUSION Fluvastatin treatment improves the expressions of ADMR mRNA and protein in the ascending aorta and the ADMR may play an important role in antiatherosclerosis of fluvastatin.

参考文献/References

［1］ Hinson JP, Kapas S, Smith DM. Adrenomedullin, a multifunctional regulatory peptide[J]. Endocine Rev,2000, 21(2):138-167.

[2] Imai Y, Shindo T, Maemura K, et al. Resistance to neointimal hyperplasia and fatty streak formation in mice with adrenomedullin overexpression[J]. Arterioscler Thromb Vasc Biol, 2002, 22(8):1310-1315.

[3] Kato J, Tsuruda T, Kita T, et al. Adrenomedullin: A protective factor for blood vessels[J]. Arterioscler Thromb Vasc Biol, 2005, 25(12):2480-2487.

[4] Kitamura K, Kangawa K, Kawamoto M, et al. Adrenomedullin: A novel hypotensive peptide isolated from human pheochromocytoma [J]. Biochem Biophys Res Commun, 1993, 192(2):553-560.

[5] Ishiyama Y,Kitamura K, Ichiki Y, et al. Hemodynamic effects of a novel hypotension peptide, human adrenomullin, in rats[J]. Eur J Pharmacol, 1993, 241(2-3):271-273.

[6] 朱妙章，袁文俊，吴博威，等. 心血管生理学与临床[M]. 北京：高等教育出版社， 2004:469-481.

[7] 李俊芳，傅增泮. 肾上腺髓质素的研究进展[J]. 临床荟萃, 2004, 19(32):1376-1378.

[9] Tsuruda T, Kato J, Hatakeyama K, et al. Adrenomedullin in mast cells of abdominal aortic aneurysm[J]. Cardiovasc Res, 2006, 70(1):158-64.

[10]Suzuki Y, Horio T, Nonogi H, et al. Adrenomedullin as a sensitive marker for coronary and peripheral arterial complications in patients with atherosclerotic risks[J]. Peptides, 2004, 25(8):1321-1326.

备注/Memo

备注/Memo:
收稿日期：2007-10-26.通讯作者：郑强荪，主任医师，主要从事快速心律失常及动脉粥样硬化研究Email：qingshu@fmmu.edu.cn 作者简介：张敬，医师，硕士生Email: zhangjing_xwt@163.com
更新日期/Last Update: